Spots Global Cancer Trial Database for hepatic artery embolism
Every month we try and update this database with for hepatic artery embolism cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCC | NCT04273100 | Hepatocellular ... | PD-1 mAb combin... | 18 Years - | Tianjin Medical University Cancer Institute and Hospital | |
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC | NCT04518852 | Hepatocellular ... Liver Neoplasms Digestive Syste... Sorafenib Molecular Mecha... Liver Diseases Antineoplastic ... Protein Kinase ... | TACE combined w... | 18 Years - | Sichuan Cancer Hospital and Research Institute |